Michael is a program and alliance management leader with 20 years of drug development experience in programs ranging from pre-clinical to Commercialization. He has worked on launching new products across multiple therapeutic areas, including rare diseases (hemophilia and amyloidosis), RA, and oncology (metastatic liver disease). Notable experience includes work in the regulatory, supply chain, manufacturing strategy, and operations fields. His track record has seen the application of those talents in combination products, microbiome, biologics, small molecules, and generic therapeutics. As an experienced Program Management Organization (PMO) leader, Michael establishes best practices, systems, and tools to ensure effective organizational management.